Century Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	52.59	47.32	84.27	56.45	27.21	44.06
Short-Term Investments	145.52	125.41	231.23	166.43	48.54	37.48
Cash & Short-Term Investments	198.11	172.74	315.5	222.88	75.75	81.54
Cash Growth	16.88%	-45.25%	41.56%	194.22%	-7.10%	-
Other Receivables	1.35	2.24	0.78	0.25	0.91	0.12
Receivables	1.35	2.24	0.78	0.25	0.91	0.12
Prepaid Expenses	6.55	0.76	1.45	1.61	-	-
Other Current Assets	-	1.26	1.99	3.42	2.14	2.46
Total Current Assets	206.01	176.99	319.72	228.15	78.8	84.12
Property, Plant & Equipment	94.11	92.08	111.73	69.82	24.78	2.49
Long-Term Investments	46.57	89.1	51.85	135.91	1.05	4.08
Other Long-Term Assets	3.4	2.52	3.24	3.49	2.15	0.21
Total Assets	388.62	360.69	486.54	437.38	106.78	90.9
Accounts Payable	2.6	2.74	5.45	7.6	8.08	1.55
Accrued Expenses	9.69	8.64	9.37	5.43	3.79	1.45
Current Portion of Long-Term Debt	-	-	6.5	1.04	-	-
Current Portion of Leases	3.76	1.51	0.48	0.62	0.24	-
Current Unearned Revenue	3.57	4.37	7.15	-	-	-
Other Current Liabilities	0.21	0.58	0.87	0.98	-	-
Total Current Liabilities	19.82	17.85	29.82	15.66	12.11	2.99
Long-Term Debt	-	-	3.74	8.9	9.64	-
Long-Term Leases	50.84	46.66	38.7	14.56	11.68	-
Long-Term Unearned Revenue	109.77	111.38	110.83	-	-	-
Other Long-Term Liabilities	9	0.06	0.72	2.02	-	-
Total Liabilities	192.93	175.94	183.81	41.14	33.43	2.99
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	941.19	840.41	824.29	785.05	217.83	216.91
Retained Earnings	-746.27	-655.77	-519.1	-388.17	-292.34	-238.77
Comprehensive Income & Other	0.76	0.11	-2.46	-0.65	-31.9	-70
Total Common Equity	195.69	184.75	302.74	396.24	-106.41	-91.86
Shareholders' Equity	195.69	184.75	302.74	396.24	73.35	87.9
Total Liabilities & Equity	388.62	360.69	486.54	437.38	106.78	90.9
Total Debt	54.6	48.17	49.41	25.12	21.56	-
Net Cash (Debt)	143.52	124.57	266.08	197.76	54.2	81.54
Net Cash Growth	17.70%	-53.19%	34.55%	264.89%	-33.53%	-
Net Cash Per Share	1.99	2.10	4.61	6.11	7.24	12.04
Filing Date Shares Outstanding	85.03	64.82	59.17	58.82	7.84	6.78
Total Common Shares Outstanding	84.76	60.34	58.47	55.01	7.48	6.78
Working Capital	186.19	159.15	289.9	212.5	66.69	81.13
Book Value Per Share	2.31	3.06	5.18	7.20	-14.22	-13.56
Tangible Book Value	157.16	184.75	302.74	396.24	-106.41	-91.86
Tangible Book Value Per Share	1.85	3.06	5.18	7.20	-14.22	-13.56
Machinery	33.59	30.66	30.36	19.47	9.02	2.63
Construction In Progress	-	0.12	14	32.84	5.77	-
Leasehold Improvements	61.52	60.86	48.95	8.37	1.96	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.